<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29630639</article-id><article-id pub-id-type="pmc">5891027</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0195576</article-id><article-id pub-id-type="publisher-id">PONE-D-18-03209</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Elements</subject><subj-group><subject>Oxygen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Vascular Medicine</subject><subj-group><subject>Blood Pressure</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Physics</subject><subj-group><subject>Classical Mechanics</subject><subj-group><subject>Pressure</subject><subj-group><subject>Partial Pressure</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Hematology</subject><subj-group><subject>Hemodynamics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Earth Sciences</subject><subj-group><subject>Atmospheric Science</subject><subj-group><subject>Atmospheric Chemistry</subject><subj-group><subject>Greenhouse Gases</subject><subj-group><subject>Carbon Dioxide</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Environmental Chemistry</subject><subj-group><subject>Atmospheric Chemistry</subject><subj-group><subject>Greenhouse Gases</subject><subj-group><subject>Carbon Dioxide</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Ecology and Environmental Sciences</subject><subj-group><subject>Environmental Chemistry</subject><subj-group><subject>Atmospheric Chemistry</subject><subj-group><subject>Greenhouse Gases</subject><subj-group><subject>Carbon Dioxide</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Compounds</subject><subj-group><subject>Carbon Dioxide</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Temperature</subject><subj-group><subject>Skin Temperature</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Temperature</subject><subj-group><subject>Skin Temperature</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Heart Rate</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Phenylephrine does not improve oxygenation during one-lung ventilation: A randomized, double-blind, cross-over study</article-title><alt-title alt-title-type="running-head">The effects of phenylephrine on oxygenation</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5333-9417</contrib-id><name><surname>Godai</surname><given-names>Kohei</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"/><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Hasegawa-Moriyama</surname><given-names>Maiko</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Matsunaga</surname><given-names>Akira</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Kanmura</surname><given-names>Yuichi</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"/></contrib></contrib-group><aff id="aff001"><addr-line>Department of Anesthesiology and Critical Care Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Sumitani</surname><given-names>Masahiko</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Tokai Daigaku, JAPAN</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>kxg179@icloud.com</email></corresp></author-notes><pub-date pub-type="epub"><day>9</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>4</issue><elocation-id>e0195576</elocation-id><history><date date-type="received"><day>1</day><month>2</month><year>2018</year></date><date date-type="accepted"><day>23</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Godai et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Godai et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0195576.pdf"/><abstract><sec id="sec001"><title>Background</title><p>Phenylephrine is an &#x003b1;<sub>1</sub> adrenergic receptor agonist that causes pulmonary vasoconstriction, and so may effectively enhance hypoxic pulmonary vasoconstriction (HPV). However, there is little evidence that phenylephrine augments HPV in clinical situations. This study aimed to evaluate the clinical effects of phenylephrine infusion on oxygenation during one-lung ventilation (OLV) in patients undergoing thoracic surgery.</p></sec><sec id="sec002"><title>Methods</title><p>This was a prospective, randomized, double-blind, cross-over study. Included patients were those undergoing elective thoracic surgery in the lateral decubitus position with OLV. Patients were randomly allocated to two groups. The N-P group initially had OLV with normal saline infusion for 30 minutes; after a 10 minute interval, OLV was then maintained with phenylephrine infusion for 30 minutes. The P-N group had the drug-infusion in the reverse order. The primary outcome was arterial partial pressure of oxygen. Secondary outcomes were mean arterial pressure, heart rate, pulse pressure variation, perfusion index, and difference between bladder and skin temperature. Statistical analysis was performed using the student t-test, Fisher's exact test, and ANOVA for Cross-over design. <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec><sec id="sec003"><title>Results</title><p>Twenty-nine patients were analyzed. Although phenylephrine infusion significantly increased mean arterial pressure (<italic>P</italic> &#x0003c; 0.001), arterial partial pressure of oxygen did not differ between the two timepoints (<italic>P</italic> = 0.19). There was no carryover effect in arterial partial pressure of oxygen (<italic>P</italic> = 0.14). Phenylephrine infusion significantly decreased heart rate (<italic>P</italic> = 0.02) and pulse pressure variation (<italic>P</italic> &#x0003c; 0.001).</p></sec><sec id="sec004"><title>Conclusions</title><p>Phenylephrine infusion did not improve oxygenation during OLV. The present results indicate that phenylephrine does not have clinically meaningful effects on HPV.</p></sec><sec id="sec005"><title>Trial registration</title><p>University Hospital Medical Information Network <ext-link ext-link-type="uri" xlink:href="https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000028009">000024317</ext-link></p></sec></abstract><funding-group><funding-statement>The authors received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="8"/><page-count count="14"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All the data are available in UMIN Individual Case Data Repository or figshare. <ext-link ext-link-type="uri" xlink:href="https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028009">https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028009</ext-link>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.6057752.v1">https://doi.org/10.6084/m9.figshare.6057752.v1</ext-link>.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All the data are available in UMIN Individual Case Data Repository or figshare. <ext-link ext-link-type="uri" xlink:href="https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028009">https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028009</ext-link>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.6057752.v1">https://doi.org/10.6084/m9.figshare.6057752.v1</ext-link>.</p></notes></front><body><sec sec-type="intro" id="sec006"><title>Introduction</title><p>Hypoxemia during one-lung ventilation (OLV) occurs in 5&#x02013;10% of patients, and may affect the patient safety[<xref rid="pone.0195576.ref001" ref-type="bibr">1</xref>]. Hypoxemia is primarily caused by the shunt through the non-dependent lung, with the degree of venous mixture mainly determined by the distribution of perfusion[<xref rid="pone.0195576.ref002" ref-type="bibr">2</xref>]. Perfusion of the non-dependent lung is reduced by multiple factors, one of which is hypoxic pulmonary vasoconstriction (HPV). HPV is a reflex contraction of vascular smooth muscle in the lung in response to regional hypoxia[<xref rid="pone.0195576.ref003" ref-type="bibr">3</xref>], which contributes to maintaining oxygenation during OLV. HPV is attenuated by intravenous vasodilators such as prostacyclin or calcium antagonists, and thus these drugs worsen the oxygenation status.</p><p>Phenylephrine is an &#x003b1;<sub>1</sub> adrenergic receptor agonist that causes pulmonary vasoconstriction. Phenylephrine administration may effectively enhance HPV[<xref rid="pone.0195576.ref003" ref-type="bibr">3</xref>]; however, there is little evidence that phenylephrine augments HPV in clinical situations. Two case reports showed that phenylephrine infusion improved oxygenation during general anesthesia[<xref rid="pone.0195576.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0195576.ref005" ref-type="bibr">5</xref>]. To the best of our knowledge, only one clinical study has prospectively evaluated phenylephrine infusion as a therapy for augmenting HPV in hypoxemic patients[<xref rid="pone.0195576.ref006" ref-type="bibr">6</xref>], reporting that phenylephrine improved oxygenation in patients with acute respiratory distress syndrome[<xref rid="pone.0195576.ref006" ref-type="bibr">6</xref>]. Our hypothesis was that phenylephrine infusion increased arterial partial pressure of oxygen (PaO<sub>2</sub>) during OLV. The aim of the present study was to evaluate the clinical effects of phenylephrine infusion on oxygenation during OLV in patients undergoing thoracic surgery.</p></sec><sec sec-type="materials|methods" id="sec007"><title>Materials and methods</title><p>This manuscript adheres to the applicable CONSORT guidelines. The supporting CONSORT checklist and protocol are available as <xref ref-type="supplementary-material" rid="pone.0195576.s001">S1 Fig</xref>, <xref ref-type="supplementary-material" rid="pone.0195576.s002">S1 File</xref>, <xref ref-type="supplementary-material" rid="pone.0195576.s003">S2 File</xref>. This prospective, randomized, double-blind, cross-over study was approved by the ethics committee of Kagoshima University Hospital, and was conducted from October 2016 to November 2017 at Kagoshima University Hospital. This trial was prospectively registered on a publicly accessible database (UMIN Clinical Trials Registry ID: UMIN000024317). Written informed consent was obtained from all participants.</p><p>Inclusion criteria were: patients with American Society of Anesthesiologists physical status I&#x02013;III undergoing elective thoracic surgery in the lateral decubitus position with at least 70 minutes of OLV. The original exclusion criteria were: history of stroke, uncompensated cardiac disease, or bradycardic arrhythmia. However, as arrhythmia affects the measurement of pulse pressure variation (PPV)[<xref rid="pone.0195576.ref007" ref-type="bibr">7</xref>], we decided to exclude all arrhythmic cases after the completion of the third case. None of the patients treated before the exclusion criteria were updated had arrhythmia. We changed the database information on 24th August 2017.</p><sec id="sec008"><title>Protocol</title><p>Before induction of general anesthesia, a thoracic epidural catheter (17G Tuohy needle, Hakko disposable epidural catheter; Hakko, Japan) was placed at T4 to T7 according to the incision level, and 3 mL mepivacaine 1% without epinephrine was administered. General anesthesia was induced with target-controlled infusion of propofol (2&#x02013;4 &#x003bc;g/mL), remifentanil (0.3 &#x003bc;g/kg/min), and rocuronium (0.6 mg/kg). Anesthesia was maintained with target-controlled infusion of propofol (2&#x02013;4 &#x003bc;g/mL) and remifentanil (0.1&#x02013;0.5 &#x003bc;g/kg/min), and intermittent bolus administration of rocuronium (10 mg). Bispectral index (BIS) values were monitored using a BIS Quatro sensor (Covidien, Mansfield, MA, USA), and the propofol infusion rate was adjusted to maintain BIS values between 40 and 60. No volatile anesthetics were used. The rate of remifentanil infusion was tailored to control hemodynamic responses. Rocuronium was used to maintain a train-of-four ratio of 1 or less (TOF-Watch SX, Organon, Ireland). Heart rate (HR), direct arterial blood pressure, electrocardiogram, BIS, peripheral oxygen saturation (SpO<sub>2</sub>), end-tidal carbon dioxide tension (ETCO<sub>2</sub>), PPV, perfusion index (PI) derived from the pulse oximeter plethysmographic waveform, bladder temperature, and skin temperature of the hand were continuously monitored (Life Scope J, Nihon Kohden, Japan). Intravenous fluid therapy consisted of 6% hydroxyethyl starch in saline (Voluven, Fresenius Kabi Japan, Japan) at a rate of 80 ml/h, and 4.3% dextrose solution (Soldem 3A, Terumo, Japan) at a rate of 20 ml/h. If the mean arterial pressure (MAP) was less than 50 mmHg, a bolus of ephedrine (4 mg) was administered.</p><p>The trachea was intubated with a left-sided double-lumen tube (DLT) (Blue Line, Smiths Medical International, UK: 35 or 37 F for males and 32 or 35 F for females). Positioning of the DLT was confirmed by fiberoptic bronchoscopy before and after placing the patient in the lateral decubitus position. Lung separation was confirmed by auscultation. During OLV, the lumen of the non-dependent lung was left open to air. The patients&#x02019; lungs were ventilated using an Aisys Pro anesthetic machine (GE Healthcare, Chicago, IL, USA) with an inspired oxygen fraction (FIO<sub>2</sub>) of 1.0, tidal volume of 5&#x02013;7 mL/kg of ideal bodyweight, and respiratory rate of 12 breaths/min; this was adjusted to maintain an ETCO<sub>2</sub> of 35&#x02013;45 mm Hg and a positive end-expiratory pressure of 6 cmH<sub>2</sub>O. The patients were randomly allocated to one of two groups using internet-based software in a complete randomization manner (Research Randomizer version 4.0, retrieved on October 13, 2016 from <ext-link ext-link-type="uri" xlink:href="http://www.randomizer.org/">http://www.randomizer.org/</ext-link>). The allocation was blinded for the patients, anesthesiologists, and surgeons. In the N-P group, 10 minutes after each patient&#x02019;s chest was opened, OLV was initially maintained with a normal saline infusion (20 mL/h) for 30 minutes; after a 10 minute interval, OLV was then maintained with a phenylephrine infusion (15 &#x003bc;g/min) for 30 minutes. In the P-N group, 10 minutes after each patient&#x02019;s chest was opened, OLV was initially maintained with a phenylephrine infusion (15 &#x003bc;g/min) for 30 minutes; after a 10 minute interval, OLV was then maintained with a normal saline infusion (20 mL/h) for 30 minutes. At the end of each drug infusion, arterial blood analysis was performed with a blood gas analyzer (ABL700, Radiometer, Denmark), and the MAP, HR, PPV, and PI were recorded. These measurements were recorded before any major pulmonary vessel clipping. The anesthetic management after these measurements was at the discretion of the anesthesia care provider.</p></sec><sec id="sec009"><title>Data analysis</title><p>The primary outcome was PaO<sub>2</sub>. The secondary outcomes were MAP, HR, PPV, PI, and the difference between the bladder and skin temperature (&#x00394;T). Originally, we calculated the required sample size as 35 patients using between-subject variation as follows. To detect a difference of 30 mmHg in PaO<sub>2</sub> during OLV with a two-sided approximation accepting an &#x003b1; error of 5% and a &#x003b2; error of 20%, the required study size was calculated as 29 patients based on a previous study using Power and Sample Size Calculation version 3.1.2 (Dupont WD and Plummer WD, Vanderbilt University, Nashville, TN)[<xref rid="pone.0195576.ref008" ref-type="bibr">8</xref>]. To account for patients dropping out during the study, 20% more patients were added, giving a final sample size of 35 patients. However, after completion of the study, we recognized that the sample size estimation should be based on within-individual variation, not on between-subject variation[<xref rid="pone.0195576.ref009" ref-type="bibr">9</xref>]. Hence, we performed a power analysis. The standard deviation of within-individual variation in PaO<sub>2</sub> during OLV in 40 minutes was 33 mmHg in the present study. To detect a difference of 30 mmHg in PaO<sub>2</sub> with a two-sided approximation accepting an &#x003b1; error of 5%, the power was calculated as 0.925. All data were expressed as means with standard deviations or with 95% confidence intervals. Statistical analysis was performed using the student <italic>t</italic>-test, Fisher's exact test, and ANOVA for Cross-over design (GraphPad Prism 5.0, La Jolla, CA, USA). <italic>P</italic> &#x0003c; 0.05 was considered statistically significant. All data were deposited in the public repository (<ext-link ext-link-type="uri" xlink:href="https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000028009">https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000028009</ext-link>).</p></sec></sec><sec sec-type="results" id="sec010"><title>Results</title><p>The CONSORT diagram is shown in <xref ref-type="fig" rid="pone.0195576.g001">Fig 1</xref>.</p><fig id="pone.0195576.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195576.g001</object-id><label>Fig 1</label><caption><title>The CONSORT flow diagram of the study.</title></caption><graphic xlink:href="pone.0195576.g001"/></fig><p>Of 50 patients considered eligible for the study, 13 patients were excluded due to a history of stroke or presence of a current arrhythmia, and two patients declined to participate. A total of 35 patients were included in the study; however, only the data from 29 patients were analyzed, as six patients did not receive their allocated intervention due to protocol violations. <xref ref-type="table" rid="pone.0195576.t001">Table 1</xref> shows the patients&#x02019; and surgical characteristics.</p><table-wrap id="pone.0195576.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195576.t001</object-id><label>Table 1</label><caption><title>Demographic, preoperative, and intraoperative clinical data.</title></caption><alternatives><graphic id="pone.0195576.t001g" xlink:href="pone.0195576.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Group N-P (n = 14)</th><th align="left" rowspan="1" colspan="1">Group P-N (n = 15)</th><th align="left" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (y)</td><td align="left" rowspan="1" colspan="1">68 &#x000b1; 11</td><td align="left" rowspan="1" colspan="1">68 &#x000b1; 9</td><td align="left" rowspan="1" colspan="1">0.95<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Male Sex (n)</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">0.43<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="left" rowspan="1" colspan="1">161 &#x000b1; 9</td><td align="left" rowspan="1" colspan="1">154 &#x000b1; 9</td><td align="left" rowspan="1" colspan="1">0.06<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="left" rowspan="1" colspan="1">59 &#x000b1; 11</td><td align="left" rowspan="1" colspan="1">54 &#x000b1; 14</td><td align="left" rowspan="1" colspan="1">0.29<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ASA Physical Status<break/>(1 / 2 / 3)</td><td align="left" rowspan="1" colspan="1">1 / 13 / 0</td><td align="left" rowspan="1" colspan="1">2 / 11 / 2</td><td align="left" rowspan="1" colspan="1">0.99<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Left Side of Surgery (n)</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">0.99<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Types of Surgery</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.65<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Pneumonectomy (n)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Bilobectomy (n)</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Lobectomy (n)</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Segmentectomy (n)</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Wedge resection (n)</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative FVC<break/>(% predicted)</td><td align="left" rowspan="1" colspan="1">103 &#x000b1; 19</td><td align="left" rowspan="1" colspan="1">104 &#x000b1; 14</td><td align="left" rowspan="1" colspan="1">0.94<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative FEV1<break/>(% predicted)</td><td align="left" rowspan="1" colspan="1">75 &#x000b1; 11</td><td align="left" rowspan="1" colspan="1">76 &#x000b1; 5</td><td align="left" rowspan="1" colspan="1">0.65<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of Anesthesia (min)</td><td align="left" rowspan="1" colspan="1">374 &#x000b1; 105</td><td align="left" rowspan="1" colspan="1">350 &#x000b1; 59</td><td align="left" rowspan="1" colspan="1">0.46<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of Surgery (min)</td><td align="left" rowspan="1" colspan="1">267 &#x000b1; 86</td><td align="left" rowspan="1" colspan="1">235 &#x000b1; 55</td><td align="left" rowspan="1" colspan="1">0.24<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Intraoperative Fluid Load (L)</td><td align="left" rowspan="1" colspan="1">1648 &#x000b1; 717</td><td align="left" rowspan="1" colspan="1">1383 &#x000b1; 592</td><td align="left" rowspan="1" colspan="1">0.29<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Intraoperative Urine Output (L)</td><td align="left" rowspan="1" colspan="1">408 &#x000b1; 262</td><td align="left" rowspan="1" colspan="1">557 &#x000b1; 431</td><td align="left" rowspan="1" colspan="1">0.27<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Intraoperative Blood Loss (L)</td><td align="left" rowspan="1" colspan="1">80 &#x000b1; 109</td><td align="left" rowspan="1" colspan="1">87 &#x000b1; 191</td><td align="left" rowspan="1" colspan="1">0.91<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Intraoperative Fluid Balance (L)</td><td align="left" rowspan="1" colspan="1">1188 &#x000b1; 555</td><td align="left" rowspan="1" colspan="1">872 &#x000b1; 297</td><td align="left" rowspan="1" colspan="1">0.06<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Abbreviations: ASA, American Society of Anesthesiologists; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.</p></fn><fn id="t001fn002"><p>Values expressed as mean &#x000b1; standard deviation or number.</p></fn><fn id="t001fn003"><p><sup>a</sup><italic>P</italic> values were calculated using the student <italic>t</italic>-test.</p></fn><fn id="t001fn004"><p><sup>b</sup><italic>P</italic> values were calculated using the Fisher's exact test.</p></fn></table-wrap-foot></table-wrap><p>There was no significant difference between groups in the patient demographics and surgical characteristics. Most patients underwent lobectomy. No patient had severe respiratory dysfunction, received preoperative &#x003b2;-blocker medications, or was transfused perioperatively. <xref ref-type="table" rid="pone.0195576.t002">Table 2</xref> shows the patients&#x02019; baseline hemodynamic and blood gas analysis data taken 10 minutes after the chest was opened, immediately before the interventions. HR was significantly higher in the P-N group than in the N-P group (<italic>P</italic> = 0.04), although this difference was only a mean of 6 beats/min. No patient was hypoxemic before the interventions.</p><table-wrap id="pone.0195576.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195576.t002</object-id><label>Table 2</label><caption><title>Baseline hemodynamic and arterial blood gas data immediately before the interventions.</title></caption><alternatives><graphic id="pone.0195576.t002g" xlink:href="pone.0195576.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Group N-P (n = 14)</th><th align="left" rowspan="1" colspan="1">Group P-N (n = 15)</th><th align="left" rowspan="1" colspan="1"><italic>P</italic> value<xref ref-type="table-fn" rid="t002fn003"><sup>a</sup></xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg)</td><td align="left" rowspan="1" colspan="1">143 &#x000b1; 53</td><td align="left" rowspan="1" colspan="1">181 &#x000b1; 72</td><td align="left" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg)</td><td align="left" rowspan="1" colspan="1">75 &#x000b1; 11</td><td align="left" rowspan="1" colspan="1">79 &#x000b1; 11</td><td align="left" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min)</td><td align="left" rowspan="1" colspan="1">70 &#x000b1; 7</td><td align="left" rowspan="1" colspan="1">76 &#x000b1; 7</td><td align="left" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%)</td><td align="left" rowspan="1" colspan="1">7.4 &#x000b1; 4.2</td><td align="left" rowspan="1" colspan="1">5.0 &#x000b1; 3.0</td><td align="left" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%)</td><td align="left" rowspan="1" colspan="1">1.9 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">1.8 &#x000b1; 0.8</td><td align="left" rowspan="1" colspan="1">0.77</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C)</td><td align="left" rowspan="1" colspan="1">1.2 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">1.5 &#x000b1; 0.8</td><td align="left" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL)</td><td align="left" rowspan="1" colspan="1">338 &#x000b1; 64</td><td align="left" rowspan="1" colspan="1">338 &#x000b1; 84</td><td align="left" rowspan="1" colspan="1">0.98</td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH2O)</td><td align="left" rowspan="1" colspan="1">21 &#x000b1; 3</td><td align="left" rowspan="1" colspan="1">22 &#x000b1; 3</td><td align="left" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg)</td><td align="left" rowspan="1" colspan="1">38 &#x000b1; 3</td><td align="left" rowspan="1" colspan="1">39 &#x000b1; 3</td><td align="left" rowspan="1" colspan="1">0.69</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%)</td><td align="left" rowspan="1" colspan="1">98 &#x000b1; 2</td><td align="left" rowspan="1" colspan="1">99 &#x000b1; 1</td><td align="left" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">pH</td><td align="left" rowspan="1" colspan="1">7.35 &#x000b1; 0.04</td><td align="left" rowspan="1" colspan="1">7.36 &#x000b1; 0.03</td><td align="left" rowspan="1" colspan="1">0.48</td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg)</td><td align="left" rowspan="1" colspan="1">47 &#x000b1; 5</td><td align="left" rowspan="1" colspan="1">47 &#x000b1; 4</td><td align="left" rowspan="1" colspan="1">0.76</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/mL)</td><td align="left" rowspan="1" colspan="1">0.8 &#x000b1; 0.2</td><td align="left" rowspan="1" colspan="1">0.8 &#x000b1; 0.2</td><td align="left" rowspan="1" colspan="1">0.51</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Abbreviations: &#x00394;T, difference between bladder and skin temperature; ETCO<sub>2</sub>, end-tidal carbon dioxide tension; HR, heart rate; MAP, mean arterial pressure; PaCO<sub>2</sub>, arterial partial pressure of carbon dioxide; PaO<sub>2</sub>, arterial partial pressure of oxygen; PI, perfusion index; Ppeak, peak inspiratory pressure; PPV, pulse pressure variation; SpO<sub>2</sub>, peripheral oxygen saturation; TV, total volume.</p></fn><fn id="t002fn002"><p>Values are expressed as mean &#x000b1; standard deviation.</p></fn><fn id="t002fn003"><p><sup>a</sup><italic>P</italic> values were calculated using the student <italic>t</italic>-test.</p></fn></table-wrap-foot></table-wrap><p>The primary and secondary outcomes are shown in Tables <xref ref-type="table" rid="pone.0195576.t003">3</xref>&#x02013;<xref ref-type="table" rid="pone.0195576.t005">5</xref>.</p><table-wrap id="pone.0195576.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195576.t003</object-id><label>Table 3</label><caption><title>Primary and secondary outcomes.</title></caption><alternatives><graphic id="pone.0195576.t003g" xlink:href="pone.0195576.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Treatment period</th><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Treatment sequence</th><th align="left" rowspan="1" colspan="1">1</th><th align="left" rowspan="1" colspan="1">2</th><th align="left" rowspan="1" colspan="1">Within-individual difference: N-P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>N then P</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), mean (SD)</td><td align="left" rowspan="1" colspan="1">152 (60)</td><td align="left" rowspan="1" colspan="1">208 (92)</td><td align="left" rowspan="1" colspan="1">-56 (82)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), mean (SD)</td><td align="left" rowspan="1" colspan="1">70 (10)</td><td align="left" rowspan="1" colspan="1">99 (18)</td><td align="left" rowspan="1" colspan="1">-29 (23)</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), mean (SD)</td><td align="left" rowspan="1" colspan="1">77 (10)</td><td align="left" rowspan="1" colspan="1">72 (10)</td><td align="left" rowspan="1" colspan="1">5.8 (5.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), mean (SD)</td><td align="left" rowspan="1" colspan="1">8.2 (6.3)</td><td align="left" rowspan="1" colspan="1">3.9 (2.9)</td><td align="left" rowspan="1" colspan="1">4.3 (4.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), mean (SD)</td><td align="left" rowspan="1" colspan="1">1.9 (0.7)</td><td align="left" rowspan="1" colspan="1">2.2 (1.0)</td><td align="left" rowspan="1" colspan="1">-0.3 (0.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), mean (SD)</td><td align="left" rowspan="1" colspan="1">1.0 (0.6)</td><td align="left" rowspan="1" colspan="1">1.0 (0.8)</td><td align="left" rowspan="1" colspan="1">0.0 (0.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>P then N</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), mean (SD)</td><td align="left" rowspan="1" colspan="1">211 (78)</td><td align="left" rowspan="1" colspan="1">231 (93)</td><td align="left" rowspan="1" colspan="1">-20 (58)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), mean (SD)</td><td align="left" rowspan="1" colspan="1">89 (10)</td><td align="left" rowspan="1" colspan="1">73 (8)</td><td align="left" rowspan="1" colspan="1">-16 (9)</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), mean (SD)</td><td align="left" rowspan="1" colspan="1">74 (7)</td><td align="left" rowspan="1" colspan="1">73 (9)</td><td align="left" rowspan="1" colspan="1">-0.6 (5.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), mean (SD)</td><td align="left" rowspan="1" colspan="1">3.8 (2.2)</td><td align="left" rowspan="1" colspan="1">6.5 (4.8)</td><td align="left" rowspan="1" colspan="1">2.7 (3.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), mean (SD)</td><td align="left" rowspan="1" colspan="1">2.4 (1.1)</td><td align="left" rowspan="1" colspan="1">2.2 (1.3)</td><td align="left" rowspan="1" colspan="1">-0.2 (0.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), mean (SD)</td><td align="left" rowspan="1" colspan="1">1.3 (1.2)</td><td align="left" rowspan="1" colspan="1">1.4 (1.0)</td><td align="left" rowspan="1" colspan="1">-0.1 (0.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Abbreviations: &#x00394;T, difference between bladder and skin temperature; HR, heart rate; MAP, mean arterial pressure; N, normal saline infusion; P, phenylephrine infusion; PaO<sub>2</sub>, arterial partial pressure of oxygen; PI, perfusion index; PPV, pulse pressure variation; SD, standard deviation.</p></fn><fn id="t003fn002"><p>Values expressed as mean (SD).</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone.0195576.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195576.t004</object-id><label>Table 4</label><caption><title>Primary and secondary outcomes (analysis of treatment effect).</title></caption><alternatives><graphic id="pone.0195576.t004g" xlink:href="pone.0195576.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Treatment effect</th><th align="left" rowspan="1" colspan="1">Within-individual difference: N-P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">18 (-9 to 45)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.19<xref ref-type="table-fn" rid="t004fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">22 (16 to 29)</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P &#x0003c;</italic> 0.001<xref ref-type="table-fn" rid="t004fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-2.6 (-4.8 to -0.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.02<xref ref-type="table-fn" rid="t004fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-3.4 (-5.0 to -1.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.001<xref ref-type="table-fn" rid="t004fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.3 (-0.0 to 0.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.06<xref ref-type="table-fn" rid="t004fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.0 (-0.2 to 0.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.79<xref ref-type="table-fn" rid="t004fn003"><sup>a</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>Abbreviations: 95% CI, 95% confidence interval; &#x00394;T, difference between bladder and skin temperature; HR, heart rate; MAP, mean arterial pressure; PaO2, arterial partial pressure of oxygen; PI, perfusion index; PPV, pulse pressure variation.</p></fn><fn id="t004fn002"><p>Values expressed as mean (95% CI).</p></fn><fn id="t004fn003"><p><sup>a</sup><italic>P</italic> values were calculated using ANOVA for Cross-over design.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone.0195576.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195576.t005</object-id><label>Table 5</label><caption><title>Primary and secondary outcomes (analysis of carryover effect and period effect).</title></caption><alternatives><graphic id="pone.0195576.t005g" xlink:href="pone.0195576.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Within-individual difference: N-P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Carryover effect</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">83 (-11 to 177)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.14<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-8 (-19 to 3)</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.24<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-1.5 (-12.3 to -9.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.81<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-1.8 (-6.7 to 3.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.53<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.5 (-0.8 to 1.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.52<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.7 (-0.5 to 1.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.34<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Period effect</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">38 (11 to 65)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.007<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">7 (-0 to 13)</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.05<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-3.2 (-5.4 to -1.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">HR (beats/min), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.006<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-0.8 (-2.4 to 0.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">PPV (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.30<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.0 (-0.2 to 0.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">PI (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.73<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-0.0 (-0.2 to 0.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;T (&#x000b0;C), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.67<xref ref-type="table-fn" rid="t005fn003"><sup>a</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>Abbreviations: 95% CI, 95% confidence interval; &#x00394;T, difference between bladder and skin temperature; HR, heart rate; MAP, mean arterial pressure; PaO<sub>2</sub>, arterial partial pressure of oxygen; PI, perfusion index; PPV, pulse pressure variation.</p></fn><fn id="t005fn002"><p>Values expressed as mean (95% CI).</p></fn><fn id="t005fn003"><p><sup>a</sup><italic>P</italic> values were calculated using ANOVA for Cross-over design.</p></fn></table-wrap-foot></table-wrap><p>No patient had difficulty with operated lung isolation using the DLT during OLV. There were no hypoxemic episodes or vasodilator administrations during the study period. Although phenylephrine infusion significantly increased the MAP by about 30%, the PaO<sub>2</sub> did not significantly differ between the two timepoints. Phenylephrine infusion significantly decreased HR and PPV. There was no difference in PI and &#x00394;T between the two timepoints. There was no carryover effect in the primary and secondary outcomes. The period significantly affected the PaO<sub>2</sub> and HR.</p><p>The hemodynamic and arterial blood gas data are shown in Tables <xref ref-type="table" rid="pone.0195576.t006">6</xref>&#x02013;<xref ref-type="table" rid="pone.0195576.t008">8</xref>.</p><table-wrap id="pone.0195576.t006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195576.t006</object-id><label>Table 6</label><caption><title>Hemodynamic and arterial blood gas data.</title></caption><alternatives><graphic id="pone.0195576.t006g" xlink:href="pone.0195576.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Treatment period</th><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Treatment sequence</th><th align="left" rowspan="1" colspan="1">1</th><th align="left" rowspan="1" colspan="1">2</th><th align="left" rowspan="1" colspan="1">Within-individual difference: N-P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>N then P</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL), mean (SD)</td><td align="left" rowspan="1" colspan="1">352 (80)</td><td align="left" rowspan="1" colspan="1">344 (79)</td><td align="left" rowspan="1" colspan="1">8 (24)</td></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), mean (SD)</td><td align="left" rowspan="1" colspan="1">24 (3.6)</td><td align="left" rowspan="1" colspan="1">25 (3.6)</td><td align="left" rowspan="1" colspan="1">-1.2 (1.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), mean (SD)</td><td align="left" rowspan="1" colspan="1">37 (3.1)</td><td align="left" rowspan="1" colspan="1">39 (3.4)</td><td align="left" rowspan="1" colspan="1">-1.2 (2.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), mean (SD)</td><td align="left" rowspan="1" colspan="1">99 (1.3)</td><td align="left" rowspan="1" colspan="1">99 (1.5)</td><td align="left" rowspan="1" colspan="1">-0.1 (0.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">pH, mean (SD)</td><td align="left" rowspan="1" colspan="1">7.35 (0.03)</td><td align="left" rowspan="1" colspan="1">7.35 (0.03)</td><td align="left" rowspan="1" colspan="1">0.00 (0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">pH, <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), mean (SD)</td><td align="left" rowspan="1" colspan="1">48 (3.8)</td><td align="left" rowspan="1" colspan="1">48 (3.2)</td><td align="left" rowspan="1" colspan="1">-0.9 (3.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/mL), mean (SD)</td><td align="left" rowspan="1" colspan="1">0.8 (0.1)</td><td align="left" rowspan="1" colspan="1">0.8 (0.1)</td><td align="left" rowspan="1" colspan="1">-0.0 (0.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/mL), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>P then N</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL), mean (SD)</td><td align="left" rowspan="1" colspan="1">344 (61)</td><td align="left" rowspan="1" colspan="1">339 (64)</td><td align="left" rowspan="1" colspan="1">5 (19)</td></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), mean (SD)</td><td align="left" rowspan="1" colspan="1">24 (4.3)</td><td align="left" rowspan="1" colspan="1">23 (3.6)</td><td align="left" rowspan="1" colspan="1">-0.8 (1.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), mean (SD)</td><td align="left" rowspan="1" colspan="1">39 (2.9)</td><td align="left" rowspan="1" colspan="1">38 (3.4)</td><td align="left" rowspan="1" colspan="1">-1.3 (1.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), mean (SD)</td><td align="left" rowspan="1" colspan="1">99 (1.0)</td><td align="left" rowspan="1" colspan="1">99 (1.2)</td><td align="left" rowspan="1" colspan="1">0.1 (0.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">pH, mean (SD)</td><td align="left" rowspan="1" colspan="1">7.37 (0.04)</td><td align="left" rowspan="1" colspan="1">7.38 (0.03)</td><td align="left" rowspan="1" colspan="1">0.01 (0.02)</td></tr><tr><td align="left" rowspan="1" colspan="1">pH, <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), mean (SD)</td><td align="left" rowspan="1" colspan="1">46 (4.5)</td><td align="left" rowspan="1" colspan="1">43 (4.0)</td><td align="left" rowspan="1" colspan="1">-2.6 (2.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/mL), mean (SD)</td><td align="left" rowspan="1" colspan="1">0.8 (0.3)</td><td align="left" rowspan="1" colspan="1">0.8 (0.3)</td><td align="left" rowspan="1" colspan="1">0.0 (0.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/mL), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">15</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t006fn001"><p>Abbreviations: 95% CI, 95% confidence interval; ETCO<sub>2</sub>, end-tidal carbon dioxide tension; N, normal saline infusion; P, phenylephrine infusion; PaCO<sub>2</sub>, arterial partial pressure of carbon dioxide; PaO<sub>2</sub>, arterial partial pressure of oxygen; Ppeak, peak inspiratory pressure; SD, standard deviation; SpO<sub>2</sub>, peripheral oxygen saturation; TV, total volume.</p></fn><fn id="t006fn002"><p>Values expressed as mean (SD).</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone.0195576.t007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195576.t007</object-id><label>Table 7</label><caption><title>Hemodynamic and arterial blood gas data (analysis of treatment effect).</title></caption><alternatives><graphic id="pone.0195576.t007g" xlink:href="pone.0195576.t007"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Treatment effect</th><th align="left" rowspan="1" colspan="1">Within-individual difference: N-P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TV (mL), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-6 (-14 to 2)</td></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.13<xref ref-type="table-fn" rid="t007fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">1.0 (0.4 to 1.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.003<xref ref-type="table-fn" rid="t007fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">1.3 (0.6 to 1.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> &#x0003c; 0.001 <italic>=</italic>
<strike>0.0006</strike><xref ref-type="table-fn" rid="t007fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.0 (-0.2 to 0.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.97<xref ref-type="table-fn" rid="t007fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">pH, mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-0.01 (-0.01 to 0.00)</td></tr><tr><td align="left" rowspan="1" colspan="1">pH, <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.06<xref ref-type="table-fn" rid="t007fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">1.7 (0.6 to 2.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.003<xref ref-type="table-fn" rid="t007fn003"><sup>a</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t007fn001"><p>Abbreviations: 95% CI, 95% confidence interval; ETCO<sub>2</sub>, end-tidal carbon dioxide tension; PaCO<sub>2</sub>, arterial partial pressure of carbon dioxide; PaO<sub>2</sub>, arterial partial pressure of oxygen; Ppeak, peak inspiratory pressure; SpO<sub>2</sub>, peripheral oxygen saturation.</p></fn><fn id="t007fn002"><p>Values expressed as mean (95% CI).</p></fn><fn id="t007fn003"><p><sup>a</sup><italic>P</italic> values were calculated using ANOVA for Cross-over design.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone.0195576.t008" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195576.t008</object-id><label>Table 8</label><caption><title>Hemodynamic and arterial blood gas data (carryover effect and period effect).</title></caption><alternatives><graphic id="pone.0195576.t008g" xlink:href="pone.0195576.t008"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Within-individual difference: N-P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Carryover effect</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-13 (-102 to 76)</td></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.81<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-0.7 (-5.4 to 4.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.80<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.5 (-3.5 to 4.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.85<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">1.0 (-0.6 to 2.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.29<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">pH, mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.05 (0.01 to 0.08)</td></tr><tr><td align="left" rowspan="1" colspan="1">pH, <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.04<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-5.6 (-10.2 to -1.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.049<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/mL), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-0.0 (-0.3 to 0.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/mL), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.77<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Period effect</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-2 (-10 to 6)</td></tr><tr><td align="left" rowspan="1" colspan="1">TV (mL), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.69<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.2 (-0.4 to 0.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ppeak (cmH<sub>2</sub>O), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.49<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-0.0 (-0.7 to 0.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">ETCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.94<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.1 (-0.1 to 0.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub> (%), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.26<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">pH, mean (95% CI)</td><td align="left" rowspan="1" colspan="1">0.01 (-0.00 to 0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">pH, <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.08<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-0.8 (-1.9 to 0.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.14<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/mL), mean (95% CI)</td><td align="left" rowspan="1" colspan="1">-0.0 (-0.4 to 0.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/mL), <italic>n</italic></td><td align="left" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">Paired analysis</td><td align="left" rowspan="1" colspan="1"><italic>P</italic> = 0.66<xref ref-type="table-fn" rid="t008fn003"><sup>a</sup></xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t008fn001"><p>Abbreviations: 95% CI, 95% confidence interval; ETCO<sub>2</sub>, end-tidal carbon dioxide tension; PaCO<sub>2</sub>, arterial partial pressure of carbon dioxide; PaO<sub>2</sub>, arterial partial pressure of oxygen; Ppeak, peak inspiratory pressure; SpO<sub>2</sub>, peripheral oxygen saturation.</p></fn><fn id="t008fn002"><p>Values expressed as mean (95% CI).</p></fn><fn id="t008fn003"><p><sup>a</sup><italic>P</italic> values were calculated using ANOVA for Cross-over design.</p></fn></table-wrap-foot></table-wrap><p>Carryover effects were detected in pH and PaCO<sub>2</sub>. There was no period effect among the other hemodynamic and arterial blood gas parameters. There were some differences in peak inspiratory pressure and ETCO<sub>2</sub> between the two timepoints. No patient had any surgical or other perioperative complications.</p></sec><sec sec-type="conclusions" id="sec011"><title>Discussion</title><p>Phenylephrine infusion at a rate of 15 &#x003bc;g/min did not have clinically meaningful effects on the PaO<sub>2</sub> during OLV. However, phenylephrine infusion increased the MAP by about 30%, and decreased the HR and PPV. Phenylephrine infusion did not significantly change the PI and &#x00394;T compared with saline infusion. To the best of our knowledge, the present study is the first to evaluate the clinical effects of phenylephrine infusion on oxygenation and other hemodynamic indices during OLV.</p><p>We designed the present study as a crossover trial. The crossover design can decrease the required sample size, as each subject serves as his or her own control. The short-lasting effects of phenylephrine make it suitable for use in a crossover trial. Phenylephrine is a short-acting drug that decreases blood pressure by 50% in 2&#x02013;3 minutes[<xref rid="pone.0195576.ref010" ref-type="bibr">10</xref>]. We chose a washout time of 10 minutes, as 10&#x02013;15 minutes is five times the half-life of phenylephrine. We confirmed that there was no carryover effect on the primary or secondary outcomes. As HPV is a biphasic response, it is possible that the order of drug infusion might have affected the PaO<sub>2</sub>. The first phase of HPV begins within 1 minute and reaches a plateau at 15 minutes, while the second phase of HPV begins after 40 minutes of hypoxia and peaks at 2 hours[<xref rid="pone.0195576.ref003" ref-type="bibr">3</xref>]. We considered that the effect of the second phase of HPV was non-significant because the second phase of HPV is reportedly weak[<xref rid="pone.0195576.ref003" ref-type="bibr">3</xref>]. However, the period had a significant effect on the PaO<sub>2</sub>. We usually ventilate patients with an FIO<sub>2</sub> of around 0.5 during OLV. We do not consider a difference in PaO<sub>2</sub> of less than 10 mmHg to be clinically meaningful during positive ventilation in a patient with an FIO<sub>2</sub> of 0.5. We determined the clinically significant difference in PaO<sub>2</sub> as 30 mmHg during positive ventilation with an FIO<sub>2</sub> of 1.0, which means a difference of 15 mmHg with an FIO<sub>2</sub> of 0.5. We believe that using a difference of 30 mmHg in PaO<sub>2</sub> is appropriate, as previous studies have used a difference of 40 mmHg[<xref rid="pone.0195576.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195576.ref011" ref-type="bibr">11</xref>].</p><p>The present results show that phenylephrine infusion did not enhance HPV during OLV. This differs from the results of Doering et al.[<xref rid="pone.0195576.ref006" ref-type="bibr">6</xref>], who found that phenylephrine infusion (50&#x02013;200 &#x003bc;g/min titrated to a 20% increase in MAP) improved the PaO<sub>2</sub> from 94 &#x000b1; 8 to 109 &#x000b1; 12 mmHg in patients with acute respiratory distress syndrome[<xref rid="pone.0195576.ref006" ref-type="bibr">6</xref>]; phenylephrine infusion improved oxygenation in six out of 12 patients[<xref rid="pone.0195576.ref006" ref-type="bibr">6</xref>]. Doering et al.[<xref rid="pone.0195576.ref006" ref-type="bibr">6</xref>] speculated that regional pulmonary vasoconstriction is necessary to improve oxygenation during phenylephrine infusion, as phenylephrine increased mean pulmonary pressure in phenylephrine responders but not in phenylephrine non-responders. One possible explanation for the difference between our results and those of Doering et al.[<xref rid="pone.0195576.ref006" ref-type="bibr">6</xref>] is that the pulmonary arteries in the non-dependent lung in our study were already maximally constricted, so the phenylephrine was not able to constrict these arteries. Tanaka and Dohi[<xref rid="pone.0195576.ref012" ref-type="bibr">12</xref>] showed that phenylephrine bolus injection did not affect the PaO<sub>2</sub> during OLV. Schloss et al.[<xref rid="pone.0195576.ref004" ref-type="bibr">4</xref>] reported that phenylephrine infusion increased the PaO<sub>2</sub> in a 12-year-old female who underwent OLV for anterior-posterior supine fusion. Her SpO<sub>2</sub> was only 90&#x02013;92% with OLV applying continuous positive airway pressure to the non-dependent lung[<xref rid="pone.0195576.ref004" ref-type="bibr">4</xref>]; however, a phenylephrine infusion of 0.1&#x02013;0.3 &#x003bc;g/kg/min increased the SpO<sub>2</sub> to 96&#x02013;98%[<xref rid="pone.0195576.ref004" ref-type="bibr">4</xref>]. Similarly, Sato and Kato[<xref rid="pone.0195576.ref005" ref-type="bibr">5</xref>] reported that a phenylephrine infusion of 0.1&#x02013;0.2 &#x003bc;g/kg/min increased the PaO<sub>2</sub> from 100 mmHg to 150 mmHg in a 59-year-old female who underwent general anesthesia with two-lung ventilation. It seems that the pulmonary vessels in these two previous patients still had the ability to constrict in response to phenylephrine, as there was oxygen in the lungs. It is plausible that phenylephrine infusion may be able to improve oxygenation only when the pulmonary arteries are not fully constricted. Phenylephrine infusion might be effective when the patients are hypoxemic under OLV with continuous positive airway pressure applied to the non-dependent lungs. However, further studies are needed to prove this hypothesis.</p><p>We selected the infusion rate of 15 &#x003bc;g/min based on a previous study and our own experiences[<xref rid="pone.0195576.ref013" ref-type="bibr">13</xref>]. Allen et al.[<xref rid="pone.0195576.ref013" ref-type="bibr">13</xref>] demonstrated that a phenylephrine infusion of 25 or 50 &#x003bc;g/min is effective as a prophylactic intervention to prevent maternal hypotension after spinal anesthesia for delivery via cesarean section. As general anesthesia causes less hypotension than spinal anesthesia, we decreased the infusion rate to 15 &#x003bc;g/min. The phenylephrine infusion significantly increased the MAP in the present study, indicating that the infusion rate of 15 &#x003bc;g/min was sufficient to induce vasoconstriction.</p><p>Phenylephrine infusion decreased the PPV in the present study, which is similar to the results of a previous study[<xref rid="pone.0195576.ref014" ref-type="bibr">14</xref>]. Rebet et al.[<xref rid="pone.0195576.ref014" ref-type="bibr">14</xref>] showed that bolus intravenous injection of phenylephrine significantly increased corrected flow time measured with esophageal Doppler, and decreased PPV in preload-dependent patients (those with PPV &#x02265; 13) who underwent general anesthesia. PPV and corrected flow time have been used as cardiac preload indices. It has been shown that &#x003b1;<sub>1</sub> stimulation constricts the splanchnic capacitance vasculature, which is dilated under general anesthesia, and increases venous return and cardiac preload[<xref rid="pone.0195576.ref015" ref-type="bibr">15</xref>]. Although the ability of PPV as a predictor of fluid responsiveness during OLV is debatable[<xref rid="pone.0195576.ref016" ref-type="bibr">16</xref>], at least two studies have shown that PPV can predict fluid responsiveness during OLV[<xref rid="pone.0195576.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0195576.ref018" ref-type="bibr">18</xref>]. In the present study, there were some differences in peak inspiratory pressure, ETCO<sub>2</sub>, and PaCO<sub>2</sub> between the two timepoints. However, we consider these differences to be clinically irrelevant. The increase in ETCO<sub>2</sub> might have resulted from increased cardiac output due to the aforementioned-increase in cardiac preload.</p><p>Our study has several limitations. First, we did not measure cardiac output or intrapulmonary shunt fraction, because the ethics committee of Kagoshima University Hospital declined our request of the insertion of esophageal doppler device or transesophageal echocardiography. We were not able to analyze the effects of phenylephrine on cardiac output or intrapulmonary shunt fraction, although these parameters directly affect oxygenation [<xref rid="pone.0195576.ref003" ref-type="bibr">3</xref>]. Second, it is possible that the anesthesiologists were aware of the group allocation, as phenylephrine infusion significantly increased the MAP. Hence, this could have produced a bias. However, we believe that our strict protocol minimized the effects of this potential bias.</p></sec><sec sec-type="conclusions" id="sec012"><title>Conclusion</title><p>Phenylephrine infusion does not have clinical effects on oxygenation in patients undergoing OLV. Phenylephrine infusion should be used to stabilize patients&#x02019; hemodynamic status, not to improve oxygenation during OLV.</p></sec><sec sec-type="supplementary-material" id="sec013"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0195576.s001"><label>S1 Fig</label><caption><title>This is the CONSORT checklist.</title><p>(DOC)</p></caption><media xlink:href="pone.0195576.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195576.s002"><label>S1 File</label><caption><title>Trial protocol.</title><p>Study protocol in English.</p><p>(DOCX)</p></caption><media xlink:href="pone.0195576.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195576.s003"><label>S2 File</label><caption><title>Trial protocol.</title><p>Study protocol in Japanese.</p><p>(PDF)</p></caption><media xlink:href="pone.0195576.s003.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The results of this study were partly presented at the 2017 annual meeting of American Society of Anesthesiologists in Boston. We thank Kelly Zammit, BVSc, from Edanz Group (<ext-link ext-link-type="uri" xlink:href="http://www.edanzediting.com/ac">www.edanzediting.com/ac</ext-link>), for editing a draft of this manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0195576.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Karzai</surname><given-names>W</given-names></name>, <name><surname>Schwarzkopf</surname><given-names>K</given-names></name>. <article-title>Hypoxemia during one-lung ventilation: prediction, prevention, and treatment</article-title>. <source>Anesthesiology</source>. <year>2009</year>;<volume>110</volume>(<issue>6</issue>):<fpage>1402</fpage>&#x02013;<lpage>11</lpage>. Epub 2009/05/07. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/ALN.0b013e31819fb15d">10.1097/ALN.0b013e31819fb15d</ext-link></comment> .<pub-id pub-id-type="pmid">19417615</pub-id></mixed-citation></ref><ref id="pone.0195576.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Brassard</surname><given-names>CL</given-names></name>, <name><surname>Lohser</surname><given-names>J</given-names></name>, <name><surname>Donati</surname><given-names>F</given-names></name>, <name><surname>Bussieres</surname><given-names>JS</given-names></name>. <article-title>Step-by-step clinical management of one-lung ventilation: continuing professional development</article-title>. <source>Can J Anaesth</source>. <year>2014</year>;<volume>61</volume>(<issue>12</issue>):<fpage>1103</fpage>&#x02013;<lpage>21</lpage>. Epub 2014/11/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12630-014-0246-2">10.1007/s12630-014-0246-2</ext-link></comment> .<pub-id pub-id-type="pmid">25389025</pub-id></mixed-citation></ref><ref id="pone.0195576.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Lumb</surname><given-names>AB</given-names></name>, <name><surname>Slinger</surname><given-names>P</given-names></name>. <article-title>Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications</article-title>. <source>Anesthesiology</source>. <year>2015</year>;<volume>122</volume>(<issue>4</issue>):<fpage>932</fpage>&#x02013;<lpage>46</lpage>. Epub 2015/01/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/ALN.0000000000000569">10.1097/ALN.0000000000000569</ext-link></comment> .<pub-id pub-id-type="pmid">25587641</pub-id></mixed-citation></ref><ref id="pone.0195576.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Schloss</surname><given-names>B</given-names></name>, <name><surname>Martin</surname><given-names>D</given-names></name>, <name><surname>Beebe</surname><given-names>A</given-names></name>, <name><surname>Klamar</surname><given-names>J</given-names></name>, <name><surname>Tobias</surname><given-names>JD</given-names></name>. <article-title>Phenylephrine to Treat Hypoxemia during One-Lung Ventilation in a Pediatric Patient</article-title>. <source>Thorac Cardiovasc Surg Rep</source>. <year>2013</year>;<volume>2</volume>(<issue>1</issue>):<fpage>16</fpage>&#x02013;<lpage>8</lpage>. Epub 2014/11/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1055/s-0033-1343734">10.1055/s-0033-1343734</ext-link></comment> ; PubMed Central PMCID: PMCPMC4176063.<pub-id pub-id-type="pmid">25360404</pub-id></mixed-citation></ref><ref id="pone.0195576.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Sato</surname><given-names>K</given-names></name>, <name><surname>Kato</surname><given-names>M</given-names></name>. [<article-title>Improvement in oxygenation by alpha stimulant</article-title>]. <source>Masui</source>. <year>2001</year>;<volume>50</volume>(<issue>10</issue>):<fpage>1118</fpage>&#x02013;<lpage>20</lpage>. Epub 2001/11/20. .<pub-id pub-id-type="pmid">11712347</pub-id></mixed-citation></ref><ref id="pone.0195576.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Doering</surname><given-names>EB</given-names></name>, <name><surname>Hanson</surname><given-names>CW</given-names><suffix>3rd</suffix></name>, <name><surname>Reily</surname><given-names>DJ</given-names></name>, <name><surname>Marshall</surname><given-names>C</given-names></name>, <name><surname>Marshall</surname><given-names>BE</given-names></name>. <article-title>Improvement in oxygenation by phenylephrine and nitric oxide in patients with adult respiratory distress syndrome</article-title>. <source>Anesthesiology</source>. <year>1997</year>;<volume>87</volume>(<issue>1</issue>):<fpage>18</fpage>&#x02013;<lpage>25</lpage>. Epub 1997/07/01. .<pub-id pub-id-type="pmid">9232130</pub-id></mixed-citation></ref><ref id="pone.0195576.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Biais</surname><given-names>M</given-names></name>, <name><surname>Ouattara</surname><given-names>A</given-names></name>, <name><surname>Janvier</surname><given-names>G</given-names></name>, <name><surname>Sztark</surname><given-names>F</given-names></name>. <article-title>Case scenario: respiratory variations in arterial pressure for guiding fluid management in mechanically ventilated patients</article-title>. <source>Anesthesiology</source>. <year>2012</year>;<volume>116</volume>(<issue>6</issue>):<fpage>1354</fpage>&#x02013;<lpage>61</lpage>. Epub 2012/04/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/ALN.0b013e318256ee28">10.1097/ALN.0b013e318256ee28</ext-link></comment> .<pub-id pub-id-type="pmid">22531335</pub-id></mixed-citation></ref><ref id="pone.0195576.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Montes</surname><given-names>FR</given-names></name>, <name><surname>Pardo</surname><given-names>DF</given-names></name>, <name><surname>Charris</surname><given-names>H</given-names></name>, <name><surname>Tellez</surname><given-names>LJ</given-names></name>, <name><surname>Garzon</surname><given-names>JC</given-names></name>, <name><surname>Osorio</surname><given-names>C</given-names></name>. <article-title>Comparison of two protective lung ventilatory regimes on oxygenation during one-lung ventilation: a randomized controlled trial</article-title>. <source>J Cardiothorac Surg</source>. <year>2010</year>;<volume>5</volume>:<fpage>99</fpage> Epub 2010/11/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1749-8090-5-99">10.1186/1749-8090-5-99</ext-link></comment> ; PubMed Central PMCID: PMCPMC2987929.<pub-id pub-id-type="pmid">21044330</pub-id></mixed-citation></ref><ref id="pone.0195576.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Yu</surname><given-names>T</given-names></name>, <name><surname>Hawkins</surname><given-names>BS</given-names></name>, <name><surname>Dickersin</surname><given-names>K</given-names></name>. <article-title>Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>8</issue>):<fpage>e0133023</fpage> Epub 2015/08/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0133023">10.1371/journal.pone.0133023</ext-link></comment> ; PubMed Central PMCID: PMCPMC4540315.<pub-id pub-id-type="pmid">26284684</pub-id></mixed-citation></ref><ref id="pone.0195576.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Xia</surname><given-names>J</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Yuan</surname><given-names>J</given-names></name>, <name><surname>Lu</surname><given-names>X</given-names></name>, <name><surname>Peng</surname><given-names>Z</given-names></name>, <name><surname>Yin</surname><given-names>N</given-names></name>. <article-title>Hemodynamic effects of ephedrine and phenylephrine bolus injection in patients in the prone position under general anesthesia for lumbar spinal surgery</article-title>. <source>Exp Ther Med</source>. <year>2016</year>;<volume>12</volume>(<issue>2</issue>):<fpage>1141</fpage>&#x02013;<lpage>6</lpage>. Epub 2016/07/23. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/etm.2016.3432">10.3892/etm.2016.3432</ext-link></comment> ; PubMed Central PMCID: PMCPMC4950852.<pub-id pub-id-type="pmid">27446334</pub-id></mixed-citation></ref><ref id="pone.0195576.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Unzueta</surname><given-names>MC</given-names></name>, <name><surname>Casas</surname><given-names>JI</given-names></name>, <name><surname>Moral</surname><given-names>MV</given-names></name>. <article-title>Pressure-controlled versus volume-controlled ventilation during one-lung ventilation for thoracic surgery</article-title>. <source>Anesth Analg</source>. <year>2007</year>;<volume>104</volume>(<issue>5</issue>):<fpage>1029</fpage>&#x02013;<lpage>33</lpage>, tables of contents. Epub 2007/04/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1213/01.ane.0000260313.63893.2f">10.1213/01.ane.0000260313.63893.2f</ext-link></comment> .<pub-id pub-id-type="pmid">17456648</pub-id></mixed-citation></ref><ref id="pone.0195576.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>M</given-names></name>, <name><surname>Dohi</surname><given-names>S</given-names></name>. [<article-title>The effects of ephedrine and phenylephrine on arterial partial pressure of oxygen during one-lung ventilation</article-title>]. <source>Masui</source>. <year>1994</year>;<volume>43</volume>(<issue>8</issue>):<fpage>1124</fpage>&#x02013;<lpage>9</lpage>. Epub 1994/08/01. .<pub-id pub-id-type="pmid">7933491</pub-id></mixed-citation></ref><ref id="pone.0195576.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Allen</surname><given-names>TK</given-names></name>, <name><surname>George</surname><given-names>RB</given-names></name>, <name><surname>White</surname><given-names>WD</given-names></name>, <name><surname>Muir</surname><given-names>HA</given-names></name>, <name><surname>Habib</surname><given-names>AS</given-names></name>. <article-title>A double-blind, placebo-controlled trial of four fixed rate infusion regimens of phenylephrine for hemodynamic support during spinal anesthesia for cesarean delivery</article-title>. <source>Anesth Analg</source>. <year>2010</year>;<volume>111</volume>(<issue>5</issue>):<fpage>1221</fpage>&#x02013;<lpage>9</lpage>. Epub 2010/05/25. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1213/ANE.0b013e3181e1db21">10.1213/ANE.0b013e3181e1db21</ext-link></comment> .<pub-id pub-id-type="pmid">20495139</pub-id></mixed-citation></ref><ref id="pone.0195576.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Rebet</surname><given-names>O</given-names></name>, <name><surname>Andremont</surname><given-names>O</given-names></name>, <name><surname>Gerard</surname><given-names>JL</given-names></name>, <name><surname>Fellahi</surname><given-names>JL</given-names></name>, <name><surname>Hanouz</surname><given-names>JL</given-names></name>, <name><surname>Fischer</surname><given-names>MO</given-names></name>. <article-title>Preload dependency determines the effects of phenylephrine on cardiac output in anaesthetised patients: A prospective observational study</article-title>. <source>Eur J Anaesthesiol</source>. <year>2016</year>;<volume>33</volume>(<issue>9</issue>):<fpage>638</fpage>&#x02013;<lpage>44</lpage>. Epub 2016/05/11. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/EJA.0000000000000470">10.1097/EJA.0000000000000470</ext-link></comment> .<pub-id pub-id-type="pmid">27164015</pub-id></mixed-citation></ref><ref id="pone.0195576.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Appleton</surname><given-names>C</given-names></name>, <name><surname>Olajos</surname><given-names>M</given-names></name>, <name><surname>Morkin</surname><given-names>E</given-names></name>, <name><surname>Goldman</surname><given-names>S</given-names></name>. <article-title>Alpha-1 adrenergic control of the venous circulation in intact dogs</article-title>. <source>J Pharmacol Exp Ther</source>. <year>1985</year>;<volume>233</volume>(<issue>3</issue>):<fpage>729</fpage>&#x02013;<lpage>34</lpage>. Epub 1985/06/01. .<pub-id pub-id-type="pmid">2861278</pub-id></mixed-citation></ref><ref id="pone.0195576.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Raphael</surname><given-names>J</given-names></name>, <name><surname>Regali</surname><given-names>LA</given-names></name>, <name><surname>Thiele</surname><given-names>RH</given-names></name>. <article-title>Hemodynamic monitoring in thoracic surgical patients</article-title>. <source>Curr Opin Anaesthesiol</source>. <year>2017</year>;<volume>30</volume>(<issue>1</issue>):<fpage>7</fpage>&#x02013;<lpage>16</lpage>. Epub 2016/12/29. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/ACO.0000000000000408">10.1097/ACO.0000000000000408</ext-link></comment> .<pub-id pub-id-type="pmid">28030449</pub-id></mixed-citation></ref><ref id="pone.0195576.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>JH</given-names></name>, <name><surname>Jeon</surname><given-names>Y</given-names></name>, <name><surname>Bahk</surname><given-names>JH</given-names></name>, <name><surname>Gil</surname><given-names>NS</given-names></name>, <name><surname>Hong</surname><given-names>DM</given-names></name>, <name><surname>Kim</surname><given-names>JH</given-names></name>, <etal>et al</etal>
<article-title>Pulse pressure variation as a predictor of fluid responsiveness during one-lung ventilation for lung surgery using thoracotomy: randomised controlled study</article-title>. <source>Eur J Anaesthesiol</source>. <year>2011</year>;<volume>28</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>44</lpage>. Epub 2010/11/23. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/EJA.0b013e32834089cf">10.1097/EJA.0b013e32834089cf</ext-link></comment> .<pub-id pub-id-type="pmid">21088596</pub-id></mixed-citation></ref><ref id="pone.0195576.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Fu</surname><given-names>Q</given-names></name>, <name><surname>Duan</surname><given-names>M</given-names></name>, <name><surname>Zhao</surname><given-names>F</given-names></name>, <name><surname>Mi</surname><given-names>W</given-names></name>. <article-title>Evaluation of stroke volume variation and pulse pressure variation as predictors of fluid responsiveness in patients undergoing protective one-lung ventilation</article-title>. <source>Drug Discov Ther</source>. <year>2015</year>;<volume>9</volume>(<issue>4</issue>):<fpage>296</fpage>&#x02013;<lpage>302</lpage>. Epub 2015/09/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5582/ddt.2015.01046">10.5582/ddt.2015.01046</ext-link></comment> .<pub-id pub-id-type="pmid">26370528</pub-id></mixed-citation></ref></ref-list></back></article>